Showing results (421-430 of 1,188) with videos related to
Sort By:
Pageof 119
Blood|May 20, 2006
Survival benefit with imatinib mesylate versus interferon-alpha-based regimens in newly diagnosed chronic-phase chronic myelogenous leukemiaHagop M Kantarjian, Moshe Talpaz, Susan O'Brien, et al.Pain Medicine (Malden, Mass.)|September 2, 2022
Experimental Pain Measurements Do Not Relate to Pain Intensity and Pain Cognitions in People Scheduled for Surgery for Lumbar RadiculopathyEva Huysmans, Lisa Goudman, Wouter Van Bogaert, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 4, 2011
Association of comorbidities with overall survival in myelodysplastic syndrome: development of a prognostic modelKiran Naqvi, Guillermo Garcia-Manero, Sagar Sardesai, et al.Blood|December 17, 2009
Phase 2 study of CEP-701, an orally available JAK2 inhibitor, in patients with primary or post-polycythemia vera/essential thrombocythemia myelofibrosisFabio P S Santos, Hagop M Kantarjian, Nitin Jain, et al.Cancer|May 10, 2012
Clinical and proteomic characterization of acute myeloid leukemia with mutated RASTapan M Kadia, Hagop Kantarjian, Steven Kornblau, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 16, 2012
Acute myeloid leukemia and myelodysplastic syndromes after radiation therapy are similar to de novo disease and differ from other therapy-related myeloid neoplasmsValentina Nardi, Karen M Winkfield, Chi Young Ok, et al.Cancer|July 14, 2011
A randomized study of 2 dose levels of intravenous clofarabine in the treatment of patients with higher-risk myelodysplastic syndromeStefan Faderl, Guillermo Garcia-Manero, Elias Jabbour, et al.Leukemia & Lymphoma|June 11, 2021
What is the optimal time to initiate hypomethylating agents (HMAs) in higher risk myelodysplastic syndromes (MDSs)?Rami Komrokji, Najla Al Ali, Eric Padron, et al.Cancer|October 21, 2010
A phase 1-2 study of a farnesyltransferase inhibitor, tipifarnib, combined with idarubicin and cytarabine for patients with newly diagnosed acute myeloid leukemia and high-risk myelodysplastic syndromeElias Jabbour, Hagop Kantarjian, Farhad Ravandi, et al.Antimicrobial Agents and Chemotherapy|January 27, 2006
Aspergillus fumigatus C-5 sterol desaturases Erg3A and Erg3B: role in sterol biosynthesis and antifungal drug susceptibilityLaura Alcazar-Fuoli, Emilia Mellado, Guillermo Garcia-Effron, et al.Pageof 119